Peregrine Capital Management LLC Inogen Inc Transaction History

Peregrine Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 16, 2019	SELL	$41.82 - $66.71 $6.81 Million - $10.9 Million	-162,844 Closed	0 $0
Q2 2019 Jul 18, 2019	SELL	$63.19 - $95.15 $2.87 Million - $4.33 Million	-45,483 Reduced 21.83%	162,844 $0
Q1 2019 Apr 12, 2019	BUY	$90.12 - $152.23 $3.07 Million - $5.18 Million	34,022 Added 19.52%	208,327 $0
Q4 2018 Jan 17, 2019	BUY	$112.83 - $239.74 $4.64 Million - $9.86 Million	41,108 Added 30.86%	174,305 $21.6 Million
Q3 2018 Oct 18, 2018	SELL	$189.1 - $282.92 $11.9 Million - $17.8 Million	-63,064 Reduced 32.13%	133,197 $0
Q2 2018 Jul 12, 2018	SELL	$123.8 - $192.48 $1.29 Million - $2 Million	-10,386 Reduced 5.03%	196,261 $0
Q1 2018 Apr 16, 2018	SELL	$114.22 - $133.22 $1.15 Million - $1.34 Million	-10,050 Reduced 4.64%	206,647 $0
Q4 2017 Jan 24, 2018	SELL	$93.4 - $128.74 $2.1 Million - $2.9 Million	-22,490 Reduced 9.4%	216,697 $0
Q3 2017 Oct 25, 2017	BUY	$91.08 - $104.49 $21.8 Million - $25 Million	239,187	239,187 $0

136

22.1M

122K

35.4K

Ticker INGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 22,866,500
Market Cap $222M
Description
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...

Get notified when there are updates to the investment portfolio of Peregrine Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Peregrine Capital Management LLC with notifications on news.